17 results
·
15ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Sensor, Glucose, Invasive, Non-Adjunctive
FDA Pre-Market Approval
FDA Class 3
·Simplera System
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
FDA Pre-Market Approval
FDA Class 3
·DAKOCYTOMATION EGFR PHARMDX
Sensor, Glucose, Invasive, Non-Adjunctive
FDA Pre-Market Approval
FDA Class 3
·Dexcon G5 Mobile Continuous Glucose Monitoring System
Sensor, Glucose, Invasive, Non-Adjunctive
FDA Pre-Market Approval
FDA Class 3
·G5 Mobile transmitter Hardware and Firmware, G5 Mobile Continuous Glucose Monitoring System
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
FDA Pre-Market Approval
FDA Class 3
·EGFR pharmDx
Sensor, Glucose, Invasive, Non-Adjunctive
FDA Pre-Market Approval
FDA Class 3
·DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM
Sensor, Glucose, Invasive, Non-Adjunctive
FDA Pre-Market Approval
FDA Class 3
·DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM
Sensor, Glucose, Invasive, Non-Adjunctive
FDA Pre-Market Approval
FDA Class 3
·G5 Mobile Continuous Glucose Monitoring System
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
FDA Pre-Market Approval
FDA Class 3
·EGFR pharmDx
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
FDA Pre-Market Approval
FDA Class 3
·EGFR pharmDx
Sensor, Glucose, Invasive, Non-Adjunctive
FDA Pre-Market Approval
FDA Class 3
·Dexcom G5 Mobile Continuous Glucose Monitoring System
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
FDA Pre-Market Approval
FDA Class 3
·EGFR pharmDx
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
FDA Pre-Market Approval
FDA Class 3
·DAKOCYTOMATION EGFR PHARMDX KIT
Sensor, Glucose, Invasive, Non-Adjunctive
FDA Pre-Market Approval
FDA Class 3
·DEXCOM G4 PLATINUM CONTIUOUS GLUCOSE MONITORING SYSTEM
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
FDA Pre-Market Approval
FDA Class 3
·DAKO EGFR PHARMDX KIT
Sensor, Glucose, Invasive, Non-Adjunctive
FDA Pre-Market Approval
FDA Class 3
·Simplera (TM) System
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
FDA Pre-Market Approval
FDA Class 3
·EGFR pharmDx